Team Meg
Event: TCS New York City Marathon
Date: November 3, 2024
Help Team Meg Make a Difference in the Race Against Cancer!
Meg was diagnosed with Hodgkin's lymphoma when she was 23 years old. She was treated at MSKCC with an aggressive regimen which was ultimately successful but had many long-term side effects: eventually Meg was left with a lung capacity of only 35%, which was especially devastating to a young woman who was an all-American athlete. In 2009, Meg's lungs could no longer continue the fight. While her lymphoma had remained in remission for twelve years, the side effects of her treatment caused her finally to succumb to a lung infection.
The Meg Berté Owen Survivorship Fund honors Meg's life by supporting cancer survivorship research at Memorial Sloan Kettering because, as Meg's story illustrates, entering remission is not the end of the struggle. To date the Fund has raised over $2,700,000.
We all run for survivorship to help all those young adults who have survived cancer and are still fighting.
What the Funds Have Been Used for To Date We use these funds to conduct pilot studies that then increase our ability to compete for large funds from the government. A large national study will cost around 2-3 million dollars to conduct over 5 years. We can take $15-20,000, get preliminary data, and be quite successful in then leading large studies aimed at reducing the long-term complications that patients like Meg face. Think of this as seed money!! And quite successful at that.
The Fred's Team Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant. The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites. |